| Publication |
Age (y), sex |
Phenotype |
Hb (g/dL) |
Previous BT |
VA |
VF defect |
Optic disc appearance |
Treatment |
Final VA |
Final VF |
Follow-up period (months) |
| [6] |
21, M |
Homozygous B-thal |
7.5 |
Age of 4 y (monthly) |
CF1m CF0.5m |
Constriction and superior bitemporalquadrantanopia BE |
Pale BE |
BT,RT,C,SX |
CF2m
CF1m |
Same |
96 |
| [5] |
NA |
B-thalintermedia |
NA |
NA |
20/20
20/40 |
NA |
Pale BE |
BT,C,EPO,H |
20/20
20/40 |
NA |
NA |
| [4] |
13, F |
B-thal/HbE |
7.5 |
Age of 5 y (every 3 months) |
2/60
5/60 |
Tunnel vision with constriction BE |
Pale BE |
BT,RT |
6/36
6/24 |
NA |
at least 1
week |
| [7] |
21, M |
B-thalintermedia |
8.3 |
Age of 4 y
(intermittent) |
CF2m
HM |
NA |
Chronic papilledema BE |
BT,ACE |
CF2m
CF0.5m |
NA |
13 |
| M: Male; F: Female; y: Years; B-thal: Beta Thalassemia; HbE: Hemoglobin E; Hb: Hemoglobin; BT: Blood Transfusions; VA:Visual Acuity; CF: Finger Count; m: Meter; HM:Hand Motions; VF:Visual Field; BE:Both Eyes; RT:External Radiation; C:Corticosteroids; SX:Partial Excision of Intrasellar Mass (Transphenoidal Approach); EPO:Erythropoietin; H:Hyperbaric oxygen; ACE:Acetazolamide; NA: Not Applicable. |
|
